Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

NCT00929019 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Uveal Melanoma

Interventions

BIOLOGICAL: autologous dendritic cells electroporated with mRNA

Sponsor

Radboud University Medical Center

Collaborators

[object Object]